Last reviewed · How we verify

Hydromorphone hydrochloride 4 milligrams

Tris Pharma, Inc. · Phase 1 active Small molecule

Hydromorphone hydrochloride 4 milligrams is a Small molecule drug developed by Tris Pharma, Inc.. It is currently in Phase 1 development. Also known as: Dilaudid (Trade Mark) 4 mg.

At a glance

Generic nameHydromorphone hydrochloride 4 milligrams
Also known asDilaudid (Trade Mark) 4 mg
SponsorTris Pharma, Inc.
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Hydromorphone hydrochloride 4 milligrams

What is Hydromorphone hydrochloride 4 milligrams?

Hydromorphone hydrochloride 4 milligrams is a Small molecule drug developed by Tris Pharma, Inc..

Who makes Hydromorphone hydrochloride 4 milligrams?

Hydromorphone hydrochloride 4 milligrams is developed by Tris Pharma, Inc. (see full Tris Pharma, Inc. pipeline at /company/tris-pharma-inc).

Is Hydromorphone hydrochloride 4 milligrams also known as anything else?

Hydromorphone hydrochloride 4 milligrams is also known as Dilaudid (Trade Mark) 4 mg.

What development phase is Hydromorphone hydrochloride 4 milligrams in?

Hydromorphone hydrochloride 4 milligrams is in Phase 1.

Related